REGEN-COV™ can be used by people with mild to moderate COVID-19 who: For more information about EUA’s, click here: FDA Emergency Use Authorization – COVID-19 Drugs Who can get REGEN-COV™? Food and Drug Administration (FDA) under an Emergency Use Authorization (EUA) while clinical studies continue to look at their usefulness and safety. Monoclonal antibody treatment with REGEN-COV™ is for people who have tested positive for COVID-19 and have mild to moderate symptoms. Antibodies made in a laboratory act a lot like natural antibodies to limit the amount of virus in your body. Updated 6-28-2021 What are monoclonal antibodies?Īntibodies are proteins that people’s bodies make to fight viruses, such as the virus that causes COVID-19. Patients interested in REGEN-COV™ should read the Fact Sheet for Patients, Parents and Caregivers and the Frequently Asked Questions below. Who require an increase in baseline oxygen flow rate due to COVID-19 in those on chronic oxygen therapy due to underlying non-COVID-19 related comorbidity.Who require oxygen therapy due to COVID-19, OR.Who are hospitalized due to COVID-19, OR.REGEN-COV™ IS NOT authorized for use in patients: The infusion clinic is located at Trinity Health East Ridge, 1250 21st Ave SE, Minot. If you do not have a primary care provider, call Trinity Health at 701-857-DR4U (3748).Ī Trinity Health provider working with the infusion clinic will review the referral form upon receipt and contact patients who qualify for REGEN-COV™ to coordinate services as soon as possible.Non-Trinity-Health patients – please call your primary care provider.Trinity Health patients - please call your primary care provider to request a referral for treatment.Please note that consent for treatment is required.The goal of this medication is to keep patients from worsening to the point of requiring hospitalization due to COVID-19. REGEN-COV™ was authorized by the United States Food and Drug Administration (FDA) under an Emergency Use Authorization (EUA) declaration for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients who qualify for treatment. Trinity Health has an outpatient infusion clinic for administering REGEN-COV™ (casirivimab and imdevimab), a monoclonal antibody treatment for COVID-19.
0 kommentar(er)
